The dominant-negative effect of CD95L binding-deficient CD95 variants is possibly also of relevance in tumor development as it has been observed that MMP-7 cleaves off a part of the CD95 PLAD resulting in reduced apoptosis sensitivity of tumor cells (Strand et al., 2004). This evidence concerns the gene MMP7 and neoplasm.